Professor Moshe Many to leave post as Vice Chairman effective January 1, 2014, will remain a member of the board

Posted: 10 December 2013 | | No comments yet

Amir Elstein to succeed Professor Moshe Many…


Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that the Vice Chairman of its Board of Directors, Professor Moshe Many, has requested to leave his position as Vice Chairman effective January 1, 2014, for personal reasons. Professor Many will remain a member of Teva’s Board.

Following Professor Many’s announcement, Teva’s Board of Directors announced that Amir Elstein has been appointed to the position of Vice Chairman, effective January 1, 2014, and will serve in this position until the 2014 Annual Meeting of Shareholders.

“I would like to thank Prof. Many for his outstanding service as Vice Chairman and wish Amir success in continuing Moshe’s good work,” said Teva Chairman, Dr. Phillip Frost.

Related people